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Mapuera virus (MPRV) is a paramyxovirus that was originally isolated from bats, but its host range
remains unknown. It was classified as a member of the genus Rubulavirus on the basis of structural
and genetic features. Like other rubulaviruses it encodes a V protein (MPRV/V) that functions
as an interferon (IFN) antagonist. Here we show that MPRV/V differs from the IFN antagonists of
other rubulaviruses in that it does not induce the proteasomal degradation of STAT proteins, key
factors in the IFN signalling cascade. Rather, MPRV/V prevents the nuclear translocation of
STATs in response to IFN stimulation and inhibits the formation of the transcription factor complex
ISGF3. We also show that MPRV/V blocks IFN signalling in cells from diverse mammalian species
and discuss the IFN response as a barrier to cross-species infections.
INTRODUCTION
Mapuera virus (MPRV) was isolated in 1979 from an
asymptomatic fruit bat, Sturnira lilium, in the Brazilian
rainforest. Morphological studies indicated that it was a
paramyxovirus (Zeller et al., 1989). Subsequent analysis of
its protein expression pattern and the sequence of the
nucleoprotein (NP) gene further classified MPRV as a
member of the genus Rubulavirus (Zeller et al., 1989).
Although MPRV is not thought to be pathogenic for
humans, intracranial infections of mice were shown to be
fatal (Zeller et al., 1989). Its natural host range, however, is
unknown.
The V/P gene of rubulaviruses encodes two proteins, V and
P, but no C proteins. V is produced by translation of a
faithful mRNA copy of the V/P gene. Expression of the
phosphoprotein P requires the introduction of G nucleo-
tides into the transcript, a process directed by stuttering of
the virus polymerase at an editing motif in the virus genomic
RNA (Thomas et al., 1988). Consequently, the two
translation products share a common N-terminal domain,
while their C-terminal domains, downstream of the editing
site, are unique. Paramyxovirus V proteins show significant
sequence similarity, especially in the C-terminal V-unique
region which contains seven highly conserved cysteine
residues that bind two zinc atoms (Liston & Briedis, 1994;
Paterson et al., 1995).
Following virus infection in vivo, the interferon (IFN)
response is critical in delaying virus spread and buying time
for the adaptive immune system to control the infection.
Cells of all tissues react to viral infections by activating
signalling cascades that lead to the induction of type I IFN.
The newly synthesized IFN is secreted and binds to the IFN-
a/b receptor on the surface of the infected cell and of
neighbouring cells, inducing a Jak/STAT signalling cascade.
STAT1 and STAT2 (signal transducers and activators of
transcription) are activated by phosphorylation and form
heterodimers that associate with a third factor, p48 [also
called IFN regulatory factor 9 (IRF-9) or ISGF3c]. The
resulting complex, IFN-stimulated gene factor 3 (ISGF3),
translocates to the nucleus and, through a promoter element
called ISRE (IFN-stimulated response element), induces the
transcription of IFN-stimulated genes (ISG), many of which
have antiviral activity. Certain immune cells secrete gamma
IFN (IFN-c) in response to virus infections. IFN-c signalling
also involves a Jak/STAT signalling cascade. When activated
by phosphorylation, STAT1 forms a homodimeric complex
GAF (c-activated factor) that after translocation into the
nucleus binds to promoters containing a GAS (c-activated
sequence) element, inducing the transcription of various
genes that are, among others, involved in the regulation of
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the adaptive immune response (reviewed by Goodbourn
et al., 2000; Haller et al., 2006; Sen, 2001).
Like most other viruses, paramyxoviruses have evolved
mechanisms that allow them to at least partially overcome
the IFN response in order to establish a productive infection
(reviewed by Conzelmann, 2005; Garcia-Sastre, 2004;
Horvath, 2004; Nagai & Kato, 2004; Stock et al., 2005).
They achieve this by both reducing the production of IFN by
infected cells and blocking IFN signalling. The V proteins of
many paramyxoviruses, including parainfluenza virus 5
(PIV5, previously referred to as simian virus 5 or SV5;
Chatziandreou et al., 2004) and MPRV, are able to reduce
the induction of IFN in response to dsRNA or virus infection
(Andrejeva et al., 2004; Childs et al., 2006; He et al., 2002;
Poole et al., 2002; Wansley & Parks, 2002). Central to this is
the interaction of V proteins with mda-5 (melanoma
differentiation-associated gene-5) (Andrejeva et al., 2004;
Childs et al., 2006). mda-5, like its homologue RIG-I
(retinoic acid-inducible gene-I), is a DEAD box helicase that
functions as a sensor for dsRNA and promotes activation of
the IRF-3 and NF-kB signalling cascades that ultimately
induce the expression of IFN (reviewed byHaller et al., 2006;
Sen & Sarkar, 2005).
In addition, many paramyxoviruses target cellular STAT
factors to inhibit the signalling cascade induced by IFN
(Horvath, 2004; Nagai & Kato, 2004; Stock et al., 2005).
Members of the genera Morbillivirus (Ohno et al., 2004;
Palosaari et al., 2003; Shaffer et al., 2003; Takeuchi et al., 2003;
Yokota et al., 2003) and Henipavirus (Park et al., 2003;
Rodriguez et al., 2002, 2003, 2004; Shaw et al., 2004) sequester
STAT1 and STAT2 in cytoplasmic or nuclear complexes that
affect their localization and, in the case of Nipah virus (NiV),
also their activation by Tyr-phosphorylation. Most rubula-
viruses such as PIV5,Human parainfluenzavirus 2 (hPIV2) or
Mumps virus (MuV) have been shown to target one of the
STAT factors for proteasome-mediated degradation
(Andrejeva et al., 2002a, b; Didcock et al., 1999; Kubota
et al., 2005; Parisien et al., 2001; Ulane et al., 2003, 2005;
Yokosawa et al., 2002; Young et al., 2000). The molecular
mechanism bywhich the V protein of PIV5 (PIV5/V) induces
the degradation of STAT1 has been thoroughly studied. It
involves the assembly by V of a complex of cellular factors,
including STAT1, STAT2, DDB1 (the 127 kDa subunit of the
UV-damaged DNA-binding protein) and Cullin4A (Cul4A,
an adaptor protein involved in the formation of ubiquitina-
tion complexes) (Andrejeva et al., 2002a; Lin et al., 1998;
Parisien et al., 2002b; Precious et al., 2005a, b; Ulane &
Horvath, 2002; Ulane et al., 2003). Recently, the structure of
this complex has begun to be revealed with publication of the
structure for DDB1 and V (Li et al., 2006). The complex
constitutes a functional E3 ubiquitin ligase that initiates the
polyubiquitination of STAT1. Ubiquitinated STAT1 is
thereby marked as a target for the proteasome and degraded.
It is likely that additional cellular factors are involved [for
example, Ulane et al. (2005) have proposed involvement of
the RING domain protein Roc1 (regulator of cullins 1)].
More recently, Precious et al. (2005a) have characterized the
formation of the complex from purified components in vitro
and propose the following model: PIV5/V is able to interact
independently with both STAT2 and DDB1. DDB1 recruits
cellular components like Cul4A that are part of the
ubiquitination machinery. STAT1 itself does not interact
directly with PIV5/V, but as STAT1 and STAT2 form
transient heterodimers even under non-induced conditions
(Braunstein et al., 2003; Precious et al., 2005a), it is recruited
into the complex via its association with STAT2. The loss of
STAT1 by degradation destabilizes the interaction of V/
DDB1/Cul4A with STAT2, which would facilitate its
replacement with a new STAT1/2 heterodimer. The
involvement of STAT2 is particularly interesting in this
context in that it confers species specificity to the process.
Due to the divergence of murine and human STAT2, PIV5
does not induce degradation of STAT1 in murine cells
(Young et al., 2001), but is able to use exogenously supplied
human STAT2 to form a functional complex that induces
the degradation of endogenous murine STAT1 (Parisien
et al., 2002a). The inability of PIV5 to block the IFN
response in mice is thus one host-range barrier that the virus
would need to overcome if it were to adapt to naturally
infect mice.
METHODS
Cells. Vero (monkey kidney), HeLa (human cervical carcinoma),
Hep2 (human larynx carcinoma), PK15 or PKIBRS2 (porcine
kidney), BF (BALB/c fibroblast), NBL6 (horse dermis), MDCK
(canine kidney), Tb1-Lu (bat lung fibroblasts) and 2fTGH (human
fibrosarcoma) cells were used. Transfections for luciferase reporter
assays were carried out using Lipofectamine (Invitrogen); all other
transfections were done using FuGENE (Roche).
Viruses. PIV5 strain W3A (Choppin, 1964), rPIV5VDC (He et al.,
2002) and MPRV strain BeAnn 370284 (Henderson et al., 1995)
were grown and titrated in Vero cells. For virus infections, cell
monolayers were incubated for 90 min with an appropriate dilution
of virus stock in serum-free Dulbecco’s modified Eagle’s medium.
IFN. Recombinant human IFN-aA/D (Rehberg et al., 1982) or
recombinant human IFN-c (R&D Systems) was used for stimulation
of human and simian cells, and recombinant porcine IFN-a or
recombinant murine IFN-a for porcine or murine cells. For the pro-
duction of bat, canine or horse IFN, Tb1-Lu, MDCK or NBL6 cells
were infected with 10 p.f.u. per cell rPIV5VDC, washed three times
and incubated for 40 h. The supernatant was cleared of debris by
centrifugation at 5000 r.p.m. (4500 g) for 15 min, cleared of virus
particles by ultracentrifugation at 38 000 r.p.m. (250 000 g) for 6 h,
UV-irradiated for 2 min, stored at 270 uC and used for stimulation
of the respective cells at a dilution of 1 : 3.
Plasmids. The IFN-a/b-responsive plasmid p(9-27)4tkD(239)lucter
contained four tandem repeats of an ISRE sequence fused to the
firefly luciferase gene (King & Goodbourn, 1998). The IFN-c-
responsive plasmid p(GAS)2tkD(239)lucter contained a minimal
thymidine kinase promoter and two tandem repeats of a GAS
sequence fused to the luciferase gene (King & Goodbourn, 1998).
pJATlacZ contains a b-galactosidase gene under the control of the
rat b-actin promoter (Masson et al., 1992). pEF.plink2,
pEF.myc.IRES and pEF.PIV5/V have been described by Didcock et al.
(1999). A cDNA fragment of MPRV/V (for the sequence see
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GenBank accession no. EF035449) was amplified by PCR (forward
primer: gggccatggacctcaccttctctc; reverse primer: gggtctagatcattctt-
gatctgattc) and cloned into pEF.myc.IRES for mammalian expres-
sion of an N-terminally myc-tagged version under the control of the
EF-1a promoter. The NiV/V expression plasmid has been described
previously (Hagmaier et al., 2006).
Antibodies. Anti-STAT1 (sc-417; Santa Cruz Biotechnology), anti-
STAT1-Tyr-P (07-307; Upstate), anti-STAT2 [sc-839 (N-terminal)
and sc-476 (C-terminal); Santa Cruz Biotechnology], anti-STAT2-
Tyr-P (07-224; Upstate), anti-STAT3 (ab2984; Abcam), anti-PIV5/V
PK336 (MCA1360; Serotec), anti-MPRV/V (polyclonal mouse serum
after immunization with MPRV/V or antibodies from sheep immun-
ized with PIV5/V, affinity purified on MPRV/V), anti-myc (Clone
4A6, 05-724; Upstate, or sc-789; Santa Cruz Biotechnology) and
anti-actin (A5441; Sigma-Aldrich) were used.
Cell lines. Stable cell lines expressing the V protein of MPRV were
produced as described previously (Andrejeva et al., 2002b). Hep2
cells were transfected with pEF.myc.IRES.MPRV, selected in the pres-
ence of 400 mg geneticin ml21 and screened for expression of
MPRV/V by immunofluorescence.
IFN signalling assays. Cells were cotransfected with 350 ng p(9-
27)4tkD(239)lucter or p(GAS)2tkD(239)lucter, 350 ng pJATlacZ
and 470 ng of a V expression plasmid. Forty-eight hours post-trans-
fection, the cells were either induced or not induced with
1.86104 IU IFN-a ml21 for 4 h. Bat, dog and horse cells were
stimulated with IFN supernatant for 6 h. Luciferase and b-galact-
osidase activities were measured as described previously (King &
Goodbourn, 1994). Differences in transfection efficiency or cell
number were taken into account by dividing the luciferase values by
the b-galactosidase values. The activity induced in the absence of V
protein was set at 100%.
Immunofluorescence. Cells were grown on coverslips, fixed and
stained with specific antibodies as described previously (Randall &
Dinwoodie, 1986). Antibody binding was visualized using Texas red-
or FITC-conjugated immunoglobulins (101002, 401002, 101007 and
401007; Oxford Biotechnology). Cell nuclei were stained using DAPI
(Sigma-Aldrich).
Electrophoretic mobility shift assay (EMSA). Nuclear extracts
were incubated with a radiolabelled ISRE probe and separated on a
native polyacrylamide gel as described (Didcock et al., 1999). The
dried gels were visualized by autoradiography.
Recombinant protein capture assay. MPRV/V was cloned into
pGEX4T (Pfizer) modified to include a GST tag and a tobacco etch
virus (TEV) protease cleavage sequence N-terminal to the gene of
interest (Precious et al., 2005b). GST-PIV5/V has been described pre-
viously (Precious et al., 2005b). Recombinant baculoviruses contain-
ing human STAT2 and STAT1 genes were the kind gift of Professor I.
Julkunen (Department of Microbiology, National Public Health
Institute, Helsinki, Finland) (Fagerlund et al., 2002). Baculovirus con-
taining human DDB1 was cloned as described previously (Precious
et al., 2005a). Spodoptera frugiperda (Sf9) cells were infected with
recombinant baculoviruses and capture of proteins expressed in
extracts by GST-MPRV/V, GST-PIV5/V or GST alone was carried out
essentially as previously described (Precious et al., 2005a), followed by
analysis by 4–12% gradient SDS-PAGE (NuPage; Invitrogen).
RESULTS
V protein of MPRV inhibits IFN signalling
The V gene of MPRV (MPRV/V) was obtained by RT-PCR
from MapV strain BeAnn 370284. The cDNA sequence was
determined and deposited in GenBank (accession no.
EF035449). As in other rubulaviruses, MPRV/V is translated
from the unedited transcript of the genome, while the
mRNA for the P protein is generated by non-templated G
insertion. Comparison of the MPRV/V protein sequence
with that of other paramyxovirus V proteins showed
relatively low similarity of the P/V-common domains but
high conservation of the V-specific C terminus (see Fig. 1a),
which is to be expected for a paramyxovirus V protein. The
diagram in Fig. 1(b) compares three rubulaviruses and three
other paramyxoviruses with respect to the similarity of
either their full-length V proteins or the conserved C-
terminal ends. In accordance with the classification of
MPRV as a member of the genus Rubulavirus, the sequence
of MPRV/V is most closely related to the V sequences of
other rubulaviruses. Compared to the V protein of PIV5,
MPRV/V contains an additional C-terminal tail of 36 aa,
which is the main reason for the fact that the conserved C
terminus of PIV5/V has a lower similarity to that of MPRV/
V than to that of other rubulaviruses. A database search did
not identify any known motifs in this extension. A similar
shorter, C-terminal extension is found in the V protein of
MeV, but does not show any sequence similarity.
The MPRV/V cDNA was cloned into a mammalian
expression vector with an N-terminal myc tag and tested
for its ability to block IFN signalling in a reporter assay based
on the induction of a luciferase gene in response to
stimulation with IFN-a/b. In human HeLa cells (Fig. 1c),
the ISRE promoter was strongly induced after stimulation
with IFN-a in the absence of V protein. In the presence of the
PIV5/V or MPRV/V protein, the induction of the reporter
was almost completely abolished.We also analysed the effect
of MPRV/V on IFN-c signalling using a reporter construct
that contains a GAS instead of the ISRE promoter. Induction
of the reporter in response to IFN-c treatment was inhibited
when either PIV5/V orMPRV/Vwas expressed (not shown),
indicating that MPRV is able to block both IFN signalling
pathways.
MPRV/V prevents formation of ISGF3 complex
The final step in the IFN-a/b signalling cascade is the
binding of ISGF3 to the ISRE promoter element. To
investigate whether MPRV/V had an influence on the
formation of this complex, a stable Hep2 cell line was
generated that expressed MPRV/V. MPRV/V-expressing
and naı¨ve cells were stimulated with IFN-a or IFN-c. The
lysates were incubated with a labelled DNA fragment
containing the ISRE sequence and analysed by EMSA for the
presence of the ISGF3 complex (Fig. 2). As expected, a shift
of the ISRE band could be detected in lysates from naı¨ve
IFN-a-treated, but not IFN-c-treated or untreated cells. In
the MPRV/V-expressing cells, however, IFN-a stimulation
did not induce a shift of the labelled DNA element,
suggesting that MPRV/V interfered with the correct
formation of the ISGF3 complex.
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MPRV does not induce STAT degradation
Although it has been reported that hPIV4 does not block
IFN signalling (Nishio et al., 2005), the V proteins of all
rubulaviruses examined to date that do block IFN signalling
do so by targeting either STAT1 or STAT2 for proteasomal
degradation (Andrejeva et al., 2002a, b; Didcock et al., 1999;
Kubota et al., 2005; Parisien et al., 2001; Ulane et al., 2003,
2005; Yokosawa et al., 2002; Young et al., 2000). Given that
MPRV was a rubulavirus and that it inhibited both IFN-a/b
and IFN-c signalling, we expected its V protein to induce
STAT1 degradation. To determine if this was the case,
2fTGH cells were, or were not, infected with MPRV.
Immunofluorescence analysis confirmed an infection
efficiency of >95%. At 16 h post-infection (p.i.) the cells
were treated or not with IFN-a for 9 h. Total cell lysates were
analysed byWestern blot probed with antibodies specific for
the P and V proteins of MPRV as well as STAT1 (Fig. 3a).
Comparable amounts of lysate were loaded in each lane as
monitored by detection of cellular b-actin (bottom panel).
Surprisingly, we found no evidence for the degradation of
STAT1 in MPRV-infected cells. Furthermore, when the
same lysates were probed with antibodies specific for STAT2
(and STAT3), no reduction in the levels of these proteins
was observed. In control cells infected with PIV5, STAT1
was no longer detectable (not shown).
It was also noted in this and similar experiments that, in the
absence of exogenous IFN, STAT1 levels were higher in
MPRV-infected cells than in unstimulated uninfected cells
(STAT1 being upregulated by IFN). These results suggest
that some IFN was induced following infection with MPRV
and that, at early times p.i., IFN could signal in MPRV-
infected cells. However, the virus clearly did inhibit IFN
signalling, as the levels of STAT1 in MPRV-infected cells did
not increase further upon the addition of exogenous IFN at
16 h p.i. and were significantly lower than in uninfected
cells stimulated with IFN.
MPRV/V does not influence STAT1
phosphorylation
As MPRV was able to block both the IFN-a/b and IFN-c
signalling pathways, though not by depletion of STAT1, we
addressed its influence on the IFN-induced phosphorylation
of STAT1 at tyrosine residue 701 (Shuai et al., 1993). 2fTGH
cells were infected with MPRV, stimulated with IFN-a for
20 min and the lysates were analysed by Western blot with
antibodies against Tyr701-phosphorylated STAT1 (Fig. 3b).
In untreated cells, no Tyr701-phosphorylated STAT1 could
be detected. After IFN stimulation, a doublet band
corresponding to phosphorylated STAT1a and STAT1b
was detected both in uninfected and infected cell lysates,
Fig. 1. MPRV/V is an IFN antagonist. (a) Alignment (CLUSTALW) of amino acid sequences of the unique C-terminal end of
paramyxoviral V proteins. (b) Amino acid similarity (percentage of total residues) of full-length V proteins (left half) or
conserved C-terminal ends as shown in (a) (right half). (c) IFN signalling assay. HeLa cells were cotransfected with a
luciferase reporter construct under the control of an ISRE promoter, a b-galactosidase reporter construct under the control of
a constitutive promoter, and an effector plasmid encoding either no protein, PIV5/V or MPRV/V. Forty-eight hours post-
transfection, cells were induced or not with IFN-a for 4 h. Lysates were analysed for luciferase activity. The data show mean
values of three independent experiments. Error bars represent SD. The induction factor (mean of stimulated/unstimulated
values) is indicated below each pair of bars.
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indicating that Tyr-phosphorylation of STAT1 was not
inhibited by any of the MPRV proteins expressed during
infection. Again, some IFN seemed to have been induced
following infection as STAT1 was phosphorylated in MPRV-
infected cells in the absence of exogenous IFN. Further
analysis revealed thatMPRValso did not prevent phosphoryl-
ation of STAT2 (Fig. 3b). In addition, it appeared that the
phosphorylated forms of both STAT1 and STAT2 were
stabilized in MPRV-infected cells, as they were still
detectable after 24 h infection. Similar experiments in
Vero cells (which are deficient in IFN production)
confirmed that MPRV does not inhibit IFN-induced
phosphorylation of either STAT1 or STAT2. Phosphoryl-
ated STAT1 and STAT2 only became detectable in infected
cells after IFN treatment (Fig. 3b, bottom panels).
MPRV/V interacts with recombinant human
STAT1 and STAT2 but not DDB1
Since MPRV did not induce STAT degradation, but clearly
blocked IFN signalling, we addressed the question of
whether MPRV/V interacted directly with STAT1 and
STAT2. Furthermore, given the central role of DDB1 in
STAT degradation by the V proteins of PIV5 and PIV2, we
also examined the interaction of MPRV/V with DDB1.
STAT1, STAT2 and DDB1 were individually expressed from
recombinant baculoviruses in Sf9 cells. Soluble cell extracts
were mixed with glutathione–agarose beads saturated with
bacterially expressed GST, GST–MPRV/V or GST–PIV5/V.
Proteins recovered from the glutathione beads were
separated by gradient SDS-PAGE and visualized by
Coomassie staining (Fig. 4). No specific proteins were
captured in the absence of V protein (GST alone). GST–
MPRV/V, however, was able to capture both STAT1 and
STAT2, but not DDB1. In contrast, and as previously
reported (Precious et al., 2005a), GST–PIV5/V is able to
bind directly to STAT2 and DDB1, but not STAT1. These
observations suggest that the reason why MPRV does not
target STAT1 or STAT2 for degradation is its inability to
interact with DDB1 to form an E3 ubiquitination complex.
These results were supported by a parallel approach based
on yeast two-hybrid assays (not shown), in which MPRV/V
interacted with STAT1 and STAT2, but not with DDB1,
whereas PIV5/V interacted independently with both DDB1
and STAT2 but not STAT1.
Fig. 2. ISGF3 formation in MPRV/V-expressing cells. EMSA of
naı¨ve and myc-MPRV/V-expressing Hep2 cells after treatment
with 56104 IU human IFN-a or human IFN-c ml”1 for 100 min.
Nuclear cell extracts were prepared and incubated with a radio-
labelled probe from the ISRE of the 9–27 promoter. The
ISGF3 complex is indicated to the right of the panel.
Fig. 3. STATs in the presence of MPRV/V. (a) STAT degrada-
tion. 2fTGH cells were infected with MPRV strain BeAnn
370284 at 10 m.o.i. or mock-infected. They were stimulated
with 3.26104 U human IFNa ml”1 at 16 h p.i. or left untreated.
At 25 h p.i., the cells were harvested and the lysates were ana-
lysed by Western blot probed with monoclonal antibodies
against human STAT1, STAT2, STAT3 and cellular actin, as
well as with an antiserum raised against the P and V proteins
of MPRV. More than 95% of the cells were infected at the
time of harvest, as determined by immunofluorescence. (b)
STAT phosphorylation. 2fTGH and Vero cells were infected as
above and stimulated for 20 min with 2.56103 U human IFN-a
ml”1 at 22 h p.i. or left untreated. Cells lysates were analysed
by Western blot probed with antibodies against human Tyr701-
phosphorylated STAT1 or Tyr689-phosphorylated STAT2.
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MPRV/V prevents nuclear translocation of
STAT1 and STAT2
As MPRV/V was clearly able to bind to both STAT1 and
STAT2 and to block their function, but did not affect their
stability or activation, the inhibition may simply reflect the
physical association of MPRV/V with STATs. The V
proteins of henipa- and morbilliviruses have been shown
to work in a similar fashion to prevent import of the STATs
into the nucleus (Palosaari et al., 2003; Park et al., 2003;
Rodriguez et al., 2002, 2003, 2004; Shaw et al., 2004). We
therefore examined whether MPRV prevented IFN-induced
relocalization of STAT1 and STAT2 into the nucleus. Hep2
cells that had been transfected with a plasmid expressing
MPRV/V were stimulated with IFN for 70 min and analysed
by immunofluorescence. The cells were stained both with a
polyclonal antiserum that recognizes the P and V proteins of
MPRV and antibodies against either STAT1 (Fig. 5a) or
STAT2 (Fig. 5b). While STAT2 was localized in the
cytoplasm in the absence of IFN, STAT1, being a shuttling
protein in its inactive state (Rodriguez et al., 2004), could be
detected both in the nucleus and in the cytoplasm.
Treatment with IFN-a induced the efficient relocalization
of both STATs into the nucleus of untransfected cells. In
MPRV/V-expressing cells, however, a clear exclusion of
STAT1 and STAT2 from the nucleus was observed following
stimulation with IFN-a. The nuclear translocation of STAT1
in response to treatment with IFN-c could equally be
inhibited by expression of MPRV/V (Fig. 5a, last row).
These data strongly suggest that the V protein of MPRV
causes incorrect localization of STAT1 and STAT2, thus
disrupting both IFN-a and IFN-c signalling. The same
mislocalization was observed in MPRV-infected cells (not
shown).
MPRV inhibits IFN signalling in a wide range of
mammalian cells
Although MPRV/V was able to block IFN signalling, it
appeared to do so less efficiently than PIV5, as it allowed for
some signalling to occur early in infection. Since we had
used mainly human cells throughout this study, but MPRV
was originally isolated from fruit bats, we wondered whether
the effect of MPRV on the IFN system of bats would be
different. We first established whether MPRV/V was able to
block IFN signalling in bat cells. The IFN signalling reporter
assay described above was adapted to Tb1-Lu lung epithelial
cells from Tadarida brasiliensis. Because the bat cells were
not responsive to commercially available IFN-a, they were
stimulated instead with supernatant from Tb1-Lu cells that
had been infected with rPIV5VDC, a strong inducer of IFN
production. As is evident from Fig. 6(a), MPRV/V inhibited
the induction of an ISRE-responsive promoter as efficiently
as the V protein of NiV (NiV/V), which was used as positive
control.
We next examined whether the virus induced STAT
degradation in these cells. Tb1-Lu cells were infected with
MPRV, PIV5 or hPIV2 and the levels of STAT1 and STAT2
were monitored by Western blot. Fig. 6(b) (upper panel)
shows that while no STAT1 could be detected in cells
infected with PIV5, infection with MPRV had not led to
degradation of STAT1 in the bat cells. Neither did we notice
a reduction in MPRV on the levels of STAT2 in MPRV-
infected Tb1-Lu cells (Fig. 6b, bottom panel). Rather, they
appeared to be upregulated, as had been noted earlier in
IFN-competent human cells. hPIV2 had been included as a
control for STAT2 degradation, but induced degradation of
STAT1 rather than STAT2 in the bat cells. It has been
reported before that hPIV2 can induce degradation of either
STAT1 or STAT2 depending on the species of origin
(Precious et al., 2005b). It should also be noted that T.
brasiliensis is an insectivorous bat which is not a host species
from which MPRV has been isolated. Unfortunately this is
the only bat species from which cultured cells are currently
available. Nevertheless, given that we have never observed
the degradation of either STAT1 or STAT2 by MPRV in a
wide variety of cells, it seems likely that MPRV/V also blocks
IFN signalling in cells of its natural host via sequestration of
STAT1 and STAT2 in an inactive form in the cytoplasm,
rather than targeting them for degradation.
As part of our work on determining the constraints that
prevent viruses from crossing species barriers, we were
interested in determining whether MPRV/V blocked IFN
signalling in cells from different mammalian species. Thus
the signalling reporter assay was adapted to cells from a
variety of different species and the ability of MPRV/V to
block IFN signalling in these cells was analysed. These
experiments showed that MPRV/V was able to inhibit IFN-
a/b signalling in human and bat cells (Figs 1c, 6a), as well as
Fig. 4. Interaction of MPRV/V with cellular factors. Purified
GST-tagged V proteins or GST alone were coupled to glu-
tathione beads and incubated with human DDB1, STAT1 or
STAT2 expressed in the baculovirus system. Proteins bound to
beads were separated on a 4–12% gradient SDS-PAGE gel
and visualized by Coomassie staining. Bands corresponding to
DDB1, STAT1 and STAT2 are marked by asterisks.
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in monkey (Vero), dog (MDCK), horse (NBL-6) and pig
(PK15, PKIBRS2) cells, but not in murine (BF) cells (Fig. 7).
DISCUSSION
The results presented here show that, although MPRV can
block IFN signalling, unlike all other rubulaviruses so far
examined, it achieves this by sequestering STAT1 and
STAT2 in the cytoplasm rather than targeting them for
proteasome-mediated degradation. Thus the mechanism of
STAT inhibition employed by MPRV shows interesting
similarities with morbilli- and henipaviruses, but there are
also differences. The V protein of NiV, like MPRV/V,
sequesters both STAT1 and STAT2 in the cytoplasm and
prevents their import into the nucleus. However, published
data suggest that NiV/V is not able to bind both STATs
independently. Rather, the interaction of NiV/V with
STAT1 is necessary to recruit STAT2 into the complex
(Rodriguez et al., 2004). Moreover, the conserved C
terminus of NiV/V is dispensable (Park et al., 2003; Shaw
et al., 2004), while neither the N-terminal nor the C-
terminal domains of MPRV/V are functional on their own
(unpublished observations). Also, the V-STAT complex
assembled by NiV has been shown to inhibit IFN-induced
phosphorylation of STAT1 (Rodriguez et al., 2002), whereas
we did not observe an inhibitory effect of MPRV on STAT
phosphorylation. On the contrary, the phosphorylated
forms of STAT1 and STAT2 that were induced by MPRV
infection could still be detected more than 24 h p.i., which
would seem to suggest that these forms are stabilized in
MPRV-infected cells. This could be due to the fact that
MPRV inhibits the import of STATs into the nucleus, where
these proteins would normally be dephosphorylated. Like
MPRV/V, the V protein of Measles virus (MeV/V), the
prototype species of the genusMorbillivirus, prevents STAT
nuclear translocation by simple sequestration in the
cytoplasm without apparently affecting its phosphorylation
state (Palosaari et al., 2003), although the V protein of the
Fig. 5. STAT nuclear translocation. Hep2
cells were transfected with a construct
encoding myc-tagged MPRV/V. At 48 h p.i.,
the cells were stimulated with 105 IU human
IFN-a ml”1 for 70 min or left untreated. The
cells were analysed by immunofluorescence
with antibodies against (a) the V protein of
MPRV (red) and STAT1 (green), or against
(b) the V protein of MPRV (red) and STAT2
(green).
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IC-B strain of wild-type MeV has been reported to prevent
both STAT1 and STAT2 phosphorylation (Takeuchi et al.
2003). However, the N terminus of MeV/V, as well as the P
protein of MeV, appears to be functional on their own
(Ohno et al., 2004), while expression of the N terminus of
MPRV/V was not sufficient to inhibit IFN signalling. The V–
STAT complex induced by MPRV does not show strong
similarities to its closest relatives, the rubulaviruses, either.
PIV5/V does not bind directly to STAT1, but rather uses
STAT2 as an adaptor for binding STAT1 (Precious et al.,
2005a), while MPRV/V was able to interact with both STAT
poteins independently in vitro. Despite these differences,
analysis ofMPRV/V confirmed that it is clearly a rubulavirus
V protein. The protein is translated from the unedited
mRNA and shows the highest sequence similarity to other
rubulavirus V proteins.
There are a number of situations described in which the IFN
response acts as a barrier to cross-species infection by
paramyxoviruses. For example, one of the reasons why PIV5
is non-pathogenic in mice is because it fails to block IFN
signalling in murine cells (Young et al., 2001). Similarly,
Fig. 6. IFN signalling in bat cells. (a) Luciferase reporter assay.
Tb1-Lu cells were transfected as described in the legend to
Fig. 1(c). NiV/V was used as a positive control. Forty-eight
hours p.i., the cells were induced or not for 6 h with bat IFN
supernatant, and the lysates analysed for luciferase activity.
Data are plotted as described in the legend to Fig. 1(c). (b)
STAT degradation. Tb1-Lu cells were infected with MPRV,
PIV5 or hPIV2 at 10 m.o.i. or mock-infected. The lysates were
analysed by Western blot with antibodies against STAT1,
STAT2 and against the P proteins of the different viruses. More
than 95% of the cells were infected at the time of harvest.
Fig. 7. IFN signalling in various species. Representative exam-
ples of the IFN signalling assays (performed as for Fig. 1c) in
cells from different mammalian species: Vero (monkey), PK
(pig), NBL (horse), MDCK (dog), BF (mouse). Either PIV5/V or
NiV/V was used as positive control.
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Bovine respiratory syncytial virus may not be pathogenic in
humans partially because it fails to successfully overcome
the IFN response in human cells (Bossert & Conzelmann,
2002; Young et al., 2003). In the case of MPRV, the results
presented here suggest that the intrinsic ability of MPRV to
block IFN signalling would not be a significant barrier that
prevents this virus from infecting a wide variety of
mammalian species. The same also appears to be the case
for NiV, as we have recently shown that NiV/V can block
IFN signalling in a wide variety of mammalian cells
(Hagmaier et al., 2006). However, even if a paramyxovirus
such asMPRV is able to block IFN signalling and at the same
time to limit IFN production through the interaction of the
V protein with mda-5, this does not necessarily mean that
the IFN response will not be a barrier to cross-species
infection. Thus, we observed a significant upregulation of
STAT1 in MPRV-infected human cells (although not as
much as in uninfected cells treated with IFN), suggesting
that some IFN was induced in response to the infection and
that this IFN had activated STAT1 transcription through the
Jak/STAT signalling pathway. MPRV-infected cells there-
fore have time to begin to respond to any small amount of
endogenous IFN produced by the infected cells before the
virus establishes an efficient block of IFN signalling. It has to
be noted in this context that MPRV/V only binds to mda-5,
but not to RIG-I, and consequently inhibits only mda-5-
mediated, not RIG-I-mediated IFN induction (Childs et al.,
2006). As it has been shown that paramyxoviruses can
induce IFN expression through a RIG-I-mediated pathway
(Kato et al., 2006; Yoneyama et al., 2004), it is reasonable to
assume that the IFN response observed in MPRV-infected
cells was due to activation of (and failure to inhibit) RIG-I.
MPRV clearly did eventually block IFN signalling since the
addition of exogenous IFN did not bring the levels of STAT1
up in MPRV-infected cells to those observed in IFN-treated
uninfected cells. Thus there is clearly a race between the
speed by which a virus can block IFN signalling and the cells’
ability to produce and respond to IFN. Whilst there are
likely to bemany factors which influence the outcome of this
race, the balance of these factors may vary from cell to cell
and species to species.
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